×

Zoetis Current Ratio 2011-2024 | ZTS

Current and historical current ratio for Zoetis (ZTS) from 2011 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Zoetis current ratio for the three months ending September 30, 2024 was 3.69.
Zoetis Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $6.28B $1.70B 3.69
2024-06-30 $6.20B $1.80B 3.45
2024-03-31 $6.36B $1.91B 3.33
2023-12-31 $6.34B $1.89B 3.36
2023-09-30 $6.22B $1.61B 3.87
2023-06-30 $6.18B $1.77B 3.50
2023-03-31 $6.27B $1.92B 3.27
2022-12-31 $7.51B $3.17B 2.37
2022-09-30 $6.55B $2.88B 2.28
2022-06-30 $6.65B $3.05B 2.18
2022-03-31 $6.84B $3.03B 2.25
2021-12-31 $6.93B $1.80B 3.86
2021-09-30 $6.68B $1.47B 4.54
2021-06-30 $7.05B $2.09B 3.37
2021-03-31 $6.79B $2.07B 3.29
2020-12-31 $6.61B $2.17B 3.05
2020-09-30 $6.76B $2.40B 2.82
2020-06-30 $6.29B $1.81B 3.47
2020-03-31 $4.77B $1.72B 2.77
2019-12-31 $4.75B $1.81B 2.63
2019-09-30 $4.62B $1.05B 4.39
2019-06-30 $4.48B $1.08B 4.17
2019-03-31 $4.38B $1.08B 4.05
2018-12-31 $4.40B $1.22B 3.60
2018-09-30 $4.08B $1.00B 4.06
2018-06-30 $4.24B $0.97B 4.38
2018-03-31 $4.27B $1.00B 4.27
2017-12-31 $4.22B $1.09B 3.86
2017-09-30 $4.89B $1.75B 2.80
2017-06-30 $3.58B $1.78B 2.01
2017-03-31 $3.38B $1.73B 1.96
2016-12-31 $3.39B $1.12B 3.04
2016-09-30 $3.36B $1.04B 3.24
2016-06-30 $3.33B $1.04B 3.20
2016-03-31 $3.31B $1.16B 2.84
2015-12-31 $3.83B $1.78B 2.15
2015-09-30 $3.45B $1.66B 2.08
2015-06-30 $3.32B $1.57B 2.11
2015-03-31 $3.11B $1.37B 2.27
2014-12-31 $3.47B $1.09B 3.19
2014-09-30 $3.35B $1.00B 3.36
2014-06-30 $3.33B $1.06B 3.14
2014-03-31 $3.22B $1.13B 2.86
2013-12-31 $3.36B $1.42B 2.37
2013-09-30 $3.08B $1.31B 2.36
2013-06-30 $3.08B $1.32B 2.33
2013-03-31 $2.94B $1.29B 2.29
2012-12-31 $2.86B $1.12B 2.55
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $2.31B $0.84B 2.74
2010-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $73.197B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.962B 28.42
Takeda Pharmaceutical (TAK) Japan $41.905B 8.72
Merck (MKKGY) Germany $18.449B 16.52
Sandoz Group AG (SDZNY) Switzerland $18.018B 0.00
Astellas Pharma (ALPMY) Japan $17.536B 16.15
United Therapeutics (UTHR) United States $15.967B 15.71
Neurocrine Biosciences (NBIX) United States $13.877B 36.74
Summit Therapeutics (SMMT) United States $13.193B 0.00
Shionogi (SGIOY) Japan $11.859B 11.88
Madrigal Pharmaceuticals (MDGL) United States $6.797B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.514B 0.00
Corcept Therapeutics (CORT) United States $5.328B 40.36
Crinetics Pharmaceuticals (CRNX) United States $4.699B 0.00
PTC Therapeutics (PTCT) United States $3.530B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.645B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.513B 11.39
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.426B 14.50
Dyne Therapeutics (DYN) United States $2.407B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.365B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.156B 0.00
Soleno Therapeutics (SLNO) United States $1.953B 0.00
Indivior (INDV) United States $1.679B 6.84
Xencor (XNCR) United States $1.659B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.560B 0.00
Evotec AG (EVO) Germany $1.538B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.313B 0.00
Ocular Therapeutix (OCUL) United States $1.313B 0.00
Guardian Pharmacy Services (GRDN) United States $1.284B 0.00
Ardelyx (ARDX) United States $1.243B 0.00
Harrow (HROW) United States $1.189B 0.00
Enliven Therapeutics (ELVN) United States $1.094B 0.00
ARS Pharmaceuticals (SPRY) United States $1.032B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.012B 0.00
Collegium Pharmaceutical (COLL) United States $0.923B 5.04
Bioventus (BVS) United States $0.855B 27.03
Cronos Group (CRON) Canada $0.745B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.701B 0.00
Relay Therapeutics (RLAY) United States $0.700B 0.00
USANA Health Sciences (USNA) United States $0.673B 12.47
Oruka Therapeutics (ORKA) United States $0.663B 0.00
Elite Pharmaceuticals (ELTP) United States $0.598B 0.00
Savara (SVRA) United States $0.529B 0.00
Altimmune (ALT) United States $0.521B 0.00
Tourmaline Bio (TRML) United States $0.515B 0.00
ProKidney (PROK) United States $0.509B 0.00
Xeris Biopharma Holdings (XERS) United States $0.504B 0.00
OmniAb (OABI) United States $0.503B 0.00
Verve Therapeutics (VERV) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Zevra Therapeutics (ZVRA) United States $0.438B 0.00
Esperion Therapeutics (ESPR) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.423B 4.93
KalVista Pharmaceuticals (KALV) United States $0.415B 0.00
Akebia Therapeutics (AKBA) United States $0.404B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Korro Bio (KRRO) United States $0.357B 0.00
Avita Medical (RCEL) United States $0.346B 0.00
Jupiter Neurosciences (JUNS) United States $0.341B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.290B 117.64
Nature's Sunshine Products (NATR) United States $0.273B 16.24
Amylyx Pharmaceuticals (AMLX) United States $0.263B 0.00
Larimar Therapeutics (LRMR) United States $0.249B 0.00
4D Molecular Therapeutics (FDMT) United States $0.245B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Heron Therapeutics (HRTX) United States $0.230B 0.00
Inhibikase Therapeutics (IKT) United States $0.218B 0.00
Lexeo Therapeutics (LXEO) United States $0.216B 0.00
Profound Medical (PROF) Canada $0.212B 0.00
Silence Therapeutics (SLN) United Kingdom $0.207B 0.00
MediWound (MDWD) Israel $0.193B 0.00
Lyell Immunopharma (LYEL) United States $0.181B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Nektar Therapeutics (NKTR) United States $0.174B 0.00
Acrivon Therapeutics (ACRV) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.156B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
Nanobiotix S.A (NBTX) France $0.141B 0.00
Telomir Pharmaceuticals (TELO) United States $0.137B 0.00
CytoDyn (CYDY) United States $0.135B 0.00
Metagenomi (MGX) United States $0.132B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Champions Oncology (CSBR) United States $0.119B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Inotiv (NOTV) United States $0.110B 0.00
Protara Therapeutics (TARA) United States $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.098B 0.00
Fractyl Health (GUTS) United States $0.098B 0.00
Pyxis Oncology (PYXS) United States $0.093B 0.00
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Century Therapeutics (IPSC) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Assertio Holdings (ASRT) United States $0.084B 22.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Journey Medical (DERM) United States $0.083B 0.00
Avalo Therapeutics (AVTX) United States $0.081B 0.00
ESSA Pharma (EPIX) Canada $0.080B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.067B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
OptiNose (OPTN) United States $0.062B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
FibroGen (FGEN) United States $0.054B 0.00
Scienture Holdings (SCNX) United States $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
AleAnna (ANNA) United States $0.050B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.045B 0.00
Surrozen (SRZN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
BioVie (BIVI) United States $0.037B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
DURECT (DRRX) United States $0.026B 0.00
Mannatech (MTEX) United States $0.026B 0.00
Traws Pharma (TRAW) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.021B 0.00
NRx Pharmaceuticals (NRXP) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
MEI Pharma (MEIP) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
SHINECO (SISI) China $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Dominari Holdings (DOMH) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.38
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.26